[Molecular profiling in daily practice for cholangiocarcinoma]

Ann Pathol. 2022 Dec;42(6S):6S5-6S7. doi: 10.1016/S0242-6498(22)00212-7.
[Article in French]
No abstract available

Keywords: Cholangiocarcinoma; Cholangiocarcinome; FGFR2 fusion; Fusion FGFR2; IDH mutations; Mutations IDH; NGS; Targeted therapy; Thérapie ciblée.

MeSH terms

  • Bile Duct Neoplasms* / diagnosis
  • Bile Duct Neoplasms* / genetics
  • Bile Duct Neoplasms* / pathology
  • Bile Ducts, Intrahepatic / pathology
  • Cholangiocarcinoma* / diagnosis
  • Cholangiocarcinoma* / genetics
  • Cholangiocarcinoma* / pathology
  • Humans
  • Mutation
  • Signal Transduction